ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical

Palmitoyl Pentapeptide-4

Palmitoyl Pentapeptide-4

Also known as: Matrixyl, Pal-KTTKS, Palmitoyl-Lys-Thr-Thr-Lys-Ser

Overview

Key Facts

Primary Goal: Research and therapeutic applications of Palmitoyl Pentapeptide-4

KTTKS fragment mimics collagen breakdown products to trigger wound-healing response. Activates TGF-beta signaling in fibroblasts to upregulate collagen gene expression.

Dosing Information

Half-Life

~4-6 hours (topical bioactivity window)

Typical Dose

2–8 mg

Frequency

Twice daily (topical application)

Cycle Length

Continuous daily use; results typically visible after 8-12 weeks

Administration Routes:
topical

Benefits

  • Stimulates collagen I, III, and IV synthesis
  • Reduces wrinkle depth by up to 68% in clinical studies
  • Increases skin thickness and dermal density
  • Promotes fibronectin and hyaluronic acid production
  • Non-irritating and suitable for sensitive skin
  • Comparable efficacy to retinol without irritation

Side Effects

Rare mild skin irritation in hypersensitive individualsmild
Minimal to no systemic absorptionmild

Mechanism of Action

1

KTTKS fragment mimics collagen breakdown products to trigger wound-healing response

2

Activates TGF-beta signaling in fibroblasts to upregulate collagen gene expression

3

Stimulates glycosaminoglycan synthesis for improved skin hydration

4

Palmitoyl anchor facilitates stratum corneum penetration and dermal delivery

Contraindications

Do not use this peptide if any of the following apply:

  • Known allergy to any component of the formulation
  • Open wounds or severely compromised skin barrier (apply only to intact skin)

Storage & Reconstitution

Unreconstituted (Powder)

Temperature15–25°C (59–77°F)
DurationUp to 3 months

Reconstituted (Mixed)

Temperature15–25°C (59–77°F)
Duration2-4 weeks

Research Summary

Preclinical

Developed by Sederma (now part of Croda), Matrixyl was introduced in 2000 and became one of the first clinically validated cosmetic peptides. A landmark double-blind study demonstrated that 8 weeks of topical application reduced wrinkle volume by 36% and wrinkle depth by 27% compared to placebo. Subsequent studies confirmed collagen synthesis stimulation in ex vivo human skin models. It remains one of the best-studied and most widely used peptides in anti-ageing skincare.

Frequently Asked Questions

Common questions about Palmitoyl Pentapeptide-4

UK-Specific Information

Exclusive data points and guidance for UK residents using Palmitoyl Pentapeptide-4

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok